Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Chemours (CC) EBIAT (2016 - 2025)

Chemours has reported EBIAT over the past 12 years, most recently at -$47.0 million for Q4 2025.

  • Quarterly results put EBIAT at -$47.0 million for Q4 2025, down 327.27% from a year ago — trailing twelve months through Dec 2025 was -$386.0 million (down 643.66% YoY), and the annual figure for FY2025 was -$386.0 million, down 659.42%.
  • EBIAT for Q4 2025 was -$47.0 million at Chemours, down from $46.0 million in the prior quarter.
  • Over the last five years, EBIAT for CC hit a ceiling of $240.0 million in Q3 2022 and a floor of -$380.0 million in Q2 2025.
  • Median EBIAT over the past 5 years was $50.0 million (2024), compared with a mean of $31.8 million.
  • Biggest five-year swings in EBIAT: skyrocketed 1126.32% in 2021 and later plummeted 733.33% in 2025.
  • Chemours' EBIAT stood at $233.0 million in 2021, then plummeted by 141.63% to -$97.0 million in 2022, then soared by 81.44% to -$18.0 million in 2023, then skyrocketed by 38.89% to -$11.0 million in 2024, then plummeted by 327.27% to -$47.0 million in 2025.
  • The last three reported values for EBIAT were -$47.0 million (Q4 2025), $46.0 million (Q3 2025), and -$380.0 million (Q2 2025) per Business Quant data.